Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alba Velo-García, Eleana Ntatsaki & David Isenberg. (2016) The safety of pharmacological treatment options for lupus nephritis. Expert Opinion on Drug Safety 15:8, pages 1041-1054.
Read now
Read now
Victor R. Pimentel-Quiroz, Manuel F. Ugarte-Gil & Graciela S. Alarcón. (2016) Abatacept for the treatment of systemic lupus erythematosus. Expert Opinion on Investigational Drugs 25:4, pages 493-499.
Read now
Read now
Alessia Leone, Savino Sciascia, Ameer Kamal & Munther Khamashta. (2015) Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies. Expert Review of Clinical Immunology 11:1, pages 109-116.
Read now
Read now
Alberta Hoi & Geoff Littlejohn. (2014) Is there still a role for abatacept in the treatment of lupus?. Expert Opinion on Biological Therapy 14:9, pages 1345-1350.
Read now
Read now
Articles from other publishers (10)
An Phan Thi & Hanh Tran Trong. (2019) Ecolo-urbanistic conditions of territorial zoning of the settlement system in the Mekong Delta, Vietnam. E3S Web of Conferences 91, pages 05002.
Crossref
Crossref
. Experimental and Clinical Transplantation 16:6.
Crossref
Crossref
Qian Zhao, Xia Chen, Jing Li, Ji Jiang, Mengtao Li, Wen Zhong, Zhengdong Li, Shui-on Leung, Fengchun Zhang & Pei Hu. (2016) Pharmacokinetics, Pharmacodynamics and Preliminary Observations for Clinical Activity and Safety of Multiple Doses of Human Mouse Chimeric Anti-CD22 Monoclonal Antibody (SM03) in Chinese Patients with Systemic Lupus Erythematosus. Clinical Drug Investigation 36:11, pages 889-902.
Crossref
Crossref
Davood Rostamzadeh, Seyed Rasol Razavi, Shadi Esmaeili, Sanam Dolati, Majid Ahmahi, Sanam Sadreddini, Farhad Jadidi-Niaragh & Mehdi Yousefi. (2016) Application of nanoparticle technology in the treatment of Systemic lupus erythematous. Biomedicine & Pharmacotherapy 83, pages 1154-1163.
Crossref
Crossref
Qian Zhao, Xia Chen, Yong Hou, Ji Jiang, Wen Zhong, Xuejing Yao, Wenxiang Wang, Lin Li, Jianmin Fang, Fengchun Zhang & Pei Hu. (2016) Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT-18 in Chinese Patients With Systemic Lupus Erythematosus. The Journal of Clinical Pharmacology 56:8, pages 948-959.
Crossref
Crossref
Valentina Sepe, Eleonora Distrutti, Vittorio Limongelli, Stefano Fiorucci & Angela Zampella. (2015) Steroidal scaffolds as FXR and GPBAR1 ligands: from chemistry to therapeutical application. Future Medicinal Chemistry 7:9, pages 1109-1135.
Crossref
Crossref
Zev Sthoeger, Amir Sharabi & Edna Mozes. (2014) Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus. Journal of Autoimmunity 54, pages 60-71.
Crossref
Crossref
Chih-Chuan Yu, Alessia Fornoni, Astrid Weins, Samy Hakroush, Dony Maiguel, Junichiro Sageshima, Linda Chen, Gaetano Ciancio, Mohd. Hafeez Faridi, Daniel Behr, Kirk N. Campbell, Jer-Ming Chang, Hung-Chun Chen, Jun Oh, Christian Faul, M. Amin Arnaout, Paolo Fiorina, Vineet Gupta, Anna Greka, George W. BurkeIIIIII & Peter Mundel. (2013) Abatacept in B7-1?Positive Proteinuric Kidney Disease. New England Journal of Medicine 369:25, pages 2416-2423.
Crossref
Crossref
Manuel F Ugarte-Gil & Graciela S Alarcón. (2013) Is there an effective treatment for late-onset systemic lupus erythematosus?. Aging Health 9:4, pages 437-450.
Crossref
Crossref
Ziv Paz & George C. Tsokos. (2013) New therapeutics in systemic lupus erythematosus. Current Opinion in Rheumatology 25:3, pages 297-303.
Crossref
Crossref